InterCure Ltd. (INCR)
1.70
0.03 (1.80%)
At close: Jan 15, 2025, 9:53 AM
Company Description
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally.
It offers dried cannabis inflorescences and cannabis extract mixed with oil.
The company also invests in biomed sector.
InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.
InterCure Ltd.
| Country | IL |
| IPO Date | Jan 28, 2019 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 270 |
| CEO | Alexander Rabinovich |
Contact Details
Address: 85 Medinat ha-Yehudim Street Herzliya, IL | |
| Website | https://www.intercure.co |
Stock Details
| Ticker Symbol | INCR |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001857030 |
| CUSIP Number | M549GJ111 |
| ISIN Number | IL0011063760 |
| Employer ID | 00-0000000 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Alexander Rabinovich | Chief Executive Officer & Director |
| Amos Cohen | Chief Financial Officer |
| Einat Zehavi | Vice President of Sales |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 30, 2024 | 6-K | Filing |
| Dec 20, 2024 | 6-K | Filing |
| Dec 20, 2024 | 6-K | Filing |
| Nov 25, 2024 | 6-K | Filing |
| Nov 04, 2024 | 6-K | Filing |
| Oct 28, 2024 | 6-K | Filing |
| Sep 17, 2024 | 6-K/A | [Amend] Filing |
| Sep 13, 2024 | 6-K | Filing |
| Aug 29, 2024 | 6-K | Filing |
| Aug 28, 2024 | 6-K | Filing |